Dr Mary Speir

Senior Research Scientist

BSc Hons; PhD

Mary joined the team in late 2021 as a Senior Research Scientist, where she helps coordinate important in vivo research related to autoimmune diseases and mRNA vaccines.

She works closely with Associate Professor Michael Gantier’s team at the Hudson Institute of Medical Research in Melbourne, acting as a valuable link between the two organisations and contributing to the scientific progress being made in the development and discovery of new anti-inflammatory drugs for a range of diseases.

Her background is in programmed cell death, and she has highly relevant experience running mouse models of infectious and inflammatory disease.

After completing her PhD at Monash University in 2015, Mary worked as a postdoctoral scientist in New Zealand, the US and Australia.

She maintains an Honorary position at the Hudson Institute, reinforcing the close working relationship between their team and Pharmorage and Noxopharm personnel.